10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001638833-23-000082`
Period End Date	20230630
Filing Date	20230801
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	sgry-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 109 Cash Flow Statement 70 Stockholders Equity 36 Comprehensive Income 24

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$374.30M	USD	Point-in-time
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$403.40M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$177.40M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$282.90M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$456.30M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$449.90M	USD	Point-in-time
Inventories	`InventoryNet`	$71.40M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$70.30M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$39.30M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$31.40M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$79.00M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$73.30M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	125.96M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$810.20M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	126.49M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$921.00M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $403.4 and $374.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$826.00M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $403.4 and $374.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$876.60M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	126.49M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$4.18B	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$4.29B	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$192.20M	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$190.30M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$267.20M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$279.10M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$91.50M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$105.70M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$128.10M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$144.20M	USD	Point-in-time
Total assets	`Assets`	$6.68B	USD	Point-in-time
Total assets	`Assets`	$6.62B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$131.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$151.60M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$68.90M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$64.30M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$210.10M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$198.10M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$62.80M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$64.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$458.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$493.40M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.50B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.56B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$271.40M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$264.10M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$75.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$82.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$330.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$328.10M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$341.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$342.00M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 126,492,822 and 125,960,834, respectively	`CommonStockValueOutstanding`	$1.30M	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 126,492,822 and 125,960,834, respectively	`CommonStockValueOutstanding`	$1.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.48B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.50B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$78.80M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$76.20M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-557.30M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-563.30M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$2.00B	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$2.02B	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$942.70M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$964.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.98B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.62B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.68B	USD	Point-in-time

Income Statement 109 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.33B	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$667.60M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$615.40M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.21B	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$360.80M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$181.90M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$195.20M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$397.40M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$345.10M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$182.20M	USD	1 Quarter
Supplies	`SuppliesExpense`	$370.60M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$173.50M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$147.50M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$66.70M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$130.30M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$72.90M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$43.20M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.80M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$40.20M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$20.20M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$87.00M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$41.40M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$38.50M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$75.80M	USD	2 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$952.20M	USD	2 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$480.80M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$513.50M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$1.05B	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$26.10M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$63.20M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$31.20M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$55.60M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$28.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$58.10M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$55.40M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$24.40M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$24.50M	USD	2 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$12.00M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$8.20M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$15.30M	USD	2 Qtrs
Grant funds	`GrantRevenue`	-	USD	1 Quarter
Grant funds	`GrantRevenue`	$1.30M	USD	2 Qtrs
Grant funds	`GrantRevenue`	$100.00K	USD	1 Quarter
Grant funds	`GrantRevenue`	$1.10M	USD	2 Qtrs
Net (gain) loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	2 Qtrs
Net (gain) loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.10M	USD	1 Quarter
Net (gain) loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$8.80M	USD	1 Quarter
Net (gain) loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.70M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$2.60M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$2.60M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$5.90M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$5.70M	USD	2 Qtrs
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$-4.50M	USD	2 Qtrs
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$-1.50M	USD	1 Quarter
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	Point-in-time
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	2 Qtrs
Litigation settlements	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-1.20M	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-2.60M	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-5.00M	USD	2 Qtrs
Other income, net	`OtherNonrecurringIncomeExpense`	$-900.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$570.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$538.90M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.19B	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.03B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$144.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$97.60M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$176.90M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$76.50M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-56.90M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-47.70M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-113.20M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-94.50M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$49.50M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$19.60M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$49.90M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$63.70M	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$5.60M	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-9.40M	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-7.80M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$4.30M	USD	1 Quarter
Net income	`ProfitLoss`	$15.30M	USD	1 Quarter
Net income	`ProfitLoss`	$58.90M	USD	2 Qtrs
Net income	`ProfitLoss`	$57.70M	USD	1 Quarter
Net income	`ProfitLoss`	$58.10M	USD	2 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$38.80M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$64.30M	USD	2 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$33.70M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$64.90M	USD	2 Qtrs
Net income (loss) attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$18.90M	USD	1 Quarter
Net income (loss) attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-6.20M	USD	2 Qtrs
Net income (loss) attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-18.40M	USD	1 Quarter
Net income (loss) attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-6.00M	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.05	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.21	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.07	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$0.15	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$0.15	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.05	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.07	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.21	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.45M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.90M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	125.72M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	125.46M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.45M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	125.46M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.90M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	127.37M	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$15.30M	USD	1 Quarter
Net income	`ProfitLoss`	$58.90M	USD	2 Qtrs
Net income	`ProfitLoss`	$57.70M	USD	1 Quarter
Net income	`ProfitLoss`	$58.10M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$28.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$58.10M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$55.40M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$24.40M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$17.10M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$17.90M	USD	2 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-13.10M	USD	2 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-12.40M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.30M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$8.80M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.60M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$8.00M	USD	2 Qtrs
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	2 Qtrs
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.10M	USD	1 Quarter
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$8.80M	USD	1 Quarter
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.70M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.90M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-11.50M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$800.00K	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$400.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.40M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.10M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-1.20M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-40.20M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$13.30M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-200.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$126.60M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$121.90M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$40.60M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$50.10M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$43.50M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$74.90M	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$26.10M	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	-	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$48.40M	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$65.80M	USD	2 Qtrs
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$11.50M	USD	2 Qtrs
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$26.00M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$11.60M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-141.90M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-181.40M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$33.30M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$31.50M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$26.50M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$12.40M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.40M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$75.20M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$76.90M	USD	2 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$-4.00M	USD	2 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$600.00K	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.90M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.50M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-103.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-90.20M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-162.50M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-105.50M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$227.40M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$282.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.40M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$227.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$282.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	126.49M	shares	Point-in-time
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.98B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-6.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$46.60M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$32.20M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$4.30M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.40M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$7.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.50M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$13.90M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$19.00M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$56.80M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-11.30M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-29.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$27.90M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-900.00K	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$46.10M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$24.60M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$27.70M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$30.20M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$23.80M	USD	1 Quarter
Balance at end of period (shares)	`CommonStockSharesOutstanding`	126.49M	shares	Point-in-time
Balance at end of period (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.98B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	1 Quarter
Net income	`ProfitLoss`	$15.30M	USD	1 Quarter
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	1 Quarter
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	2 Qtrs
Net income	`ProfitLoss`	$58.90M	USD	2 Qtrs
Net income	`ProfitLoss`	$57.70M	USD	1 Quarter
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	2 Qtrs
Net income	`ProfitLoss`	$58.10M	USD	2 Qtrs
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$13.90M	USD	1 Quarter
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$19.00M	USD	1 Quarter
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$75.80M	USD	2 Qtrs
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$2.60M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$133.90M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$61.50M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$34.30M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$71.60M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$64.90M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$38.80M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$64.30M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$33.70M	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$69.60M	USD	2 Qtrs
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$32.80M	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$600.00K	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-3.40M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.